Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
2.610
+0.020 (0.77%)
Nov 5, 2024, 11:17 AM EST - Market open
Protara Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for TARA stock have an average target of 24, with a low estimate of 23 and a high estimate of 25. The average target predicts an increase of 819.54% from the current stock price of 2.61.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 12, 2024.
Analyst Ratings
The average analyst rating for TARA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $30 → $25 | Buy | Maintains | $30 → $25 | +857.85% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +781.23% | Aug 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +781.23% | May 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $26 → $30 | Buy | Maintains | $26 → $30 | +1,049.43% | Apr 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +781.23% | Apr 8, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.12
from -3.57
EPS Next Year
-3.26
from -3.12
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 11.7M | ||
| Avg | n/a | n/a | 3.8M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.33 | -1.62 | -1.29 | ||
| Avg | -3.12 | -3.26 | -2.42 | ||
| Low | -5.24 | -5.83 | -3.06 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.